Trials / Completed
CompletedNCT00040495
Study Evaluating Pantoprazole in Peptic Ulcer Hemorrhage
An Efficacy and Safety Study of Intravenous Pantoprazole in the Prevention of Recurrent Peptic Ulcer Bleeding After Successful Hemostasis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 149 (actual)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of intravenous pantoprazole in the prevention of rebleeding in patients with bleeding peptic ulcer disease after successful endoscopic hemostatic therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pantoprazole |
Timeline
- Start date
- 2001-04-01
- Primary completion
- 2003-01-01
- Completion
- 2003-01-01
- First posted
- 2002-06-28
- Last updated
- 2013-02-08
Source: ClinicalTrials.gov record NCT00040495. Inclusion in this directory is not an endorsement.